BDFS Capital’s Johnson & Johnson JNJ Stock Holding History

BDFS Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.43M	Buy	5,616 +6	+0.1%	+$1.4K	0.62%	28
2026 Q1	$1.37M	Sell	5,610 -39	-0.7%	-$9.08K	0.66%	24
2025 Q4	$1.17M	Buy	+5,649	New	+$1.12M	0.59%	27

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BDFS Capital's JNJ Position: Q2 2026 in Review

BDFS Capital increased its Johnson & Johnson (JNJ) stake by 0.11% in Q2 2026, buying an estimated $1.4K and bringing the position to 5,616 shares worth $1.43M. The position accounts for 0.62% of the portfolio, ranked #28.

BDFS Capital first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 4,650 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

BDFS Capital held 5,616 shares of Johnson & Johnson worth $1.43M as of Q2 2026.
BDFS Capital bought 6 Johnson & Johnson shares in Q2 2026, an estimated $1.4K.
Johnson & Johnson made up 0.62% of BDFS Capital's portfolio in Q2 2026, its #28 holding.
BDFS Capital first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
4,650 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on BDFS Capital's 13F filing for Q2 2026, filed 15 Jul 2026.